|
1
|
McGuire S: World Cancer Report 2014.
Geneva, Switzerland: World Health Organization, International
Agency for Research on Cancer, WHO Press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xue P, Wu Y, Guo J and Kang Y: Highly
efficient capture and harvest of circulating tumor cells on a
microfluidic chip integrated with herringbone and micropost arrays.
Biomed Microdevices. 17:392015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mikolajczyk SD, Millar LS, Tsinberg P,
Coutts SM, Zomorrodi M, Pham T, Bischoff FZ and Pircher TJ:
Detection of EpCAM-negative and cytokeratin-negative circulating
tumor cells in peripheral blood. J Oncol. 2011:2523612011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murray NP, Miranda R, Ruiz A and Droguett
E: Diagnostic yield of primary circulating tumor cells in women
suspected of breast cancer: The BEST (Breast Early Screening Test)
study. Asian Pac J Cancer Prev. 16:1929–1934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ge F, Zhang H, Wang DD, Li L and Lin PP:
Enhanced detection and comprehensive in situ phenotypic
characterization of circulating and disseminated heteroploid
epithelial and glioma tumor cells. Oncotarget. 6:27049–27064. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harris L, Fritsche H, Mennel R, Norton L,
Ravdin P, Taube S, Somerfield MR, Hayes DF and Bast RC Jr; American
Society of Clinical Oncology, : American Society of Clinical
Oncology 2007 update of recommendations for the use of tumor
markers in breast cancer. J Clin Oncol. 25:5287–5312. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen M, Palleschi S, Khoynezhad A,
Gecelter G, Marini CP and Simms HH: Role of primary breast cancer
characteristics in predicting positive sentinel lymph node biopsy
results: A multivariate analysis. Arch Surg. 137:606–610. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mego M, Giordano A, De Giorgi U, Masuda H,
Hsu L, Giuliano M, Fouad TM, Dawood S, Ueno NT, Valero V, et al:
Circulating tumor cells in newly diagnosed inflammatory breast
cancer. Breast Cancer Res. 17:22015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yi M, Krishnamurthy S, Kuerer HM,
Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF
and Hunt KK: Role of primary tumor characteristics in predicting
positive sentinel lymph nodes in patients with ductal carcinoma in
situ or microinvasive breast cancer. Am J Surg. 196:81–87. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alix-Panabières C and Pantel K:
Circulating tumor cells: Liquid biopsy of cancer. Clin Chem.
59:110–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sheng Y, Wang T, Li H, Zhang Z, Chen J, He
C, Li Y, Lv Y, Zhang J, Xu C, et al: Comparison of analytic
performances of Cellsearch and iFISH approach in detecting
circulating tumor cells. Oncotarget. 8:8801–8806. 2017.PubMed/NCBI
|
|
12
|
Hillig T, Horn P, Nygaard AB, Haugaard AS,
Nejlund S, Brandslund I and Sölétormos G: In vitro detection of
circulating tumor cells compared by the CytoTrack and CellSearch
methods. Tumour Biol. 36:4597–4601. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Min H, Jo SM and Kim HS: Efficient capture
and simple quantification of circulating tumor cells using quantum
dots and magnetic beads. Small. 11:2536–2542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu C, Hao H, Li L, Zhou X, Guo Z, Zhang L,
Zhang X, Zhong W, Guo H, Bremner RM and Lin P: Preliminary
investigation of the clinical significance of detecting circulating
tumor cells enriched from lung cancer patients. J Thorac Oncol.
4:30–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Zhang X, Ge S, Gao J, Gong J, Lu M,
Zhang Q, Cao Y, Wang DD, Lin PP and Shen L: Clinical significance
of phenotyping and karyotyping of circulating tumor cells in
patients with advanced gastric cancer. Oncotarget. 5:6594–6602.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Wang F, Ning N, Chen Q, Yang Z,
Guo Y, Xu D, Zhang D, Zhan T and Cui W: Patterns of circulating
tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Int J Cancer. 136:1228–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao Y, Paner GP and Rajan PB: Sentinel
node status and tumor characteristics: A study of 234 invasive
breast carcinomas. Arch Pathol Lab Med. 129:82–84. 2005.PubMed/NCBI
|
|
18
|
Allred DC, Clark GM, Tandon AK, Molina R,
Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey
L, et al: HER-2/neu in node-negative breast cancer: Prognostic
significance of overexpression influenced by the presence of in
situ carcinoma. J Clin Oncol. 10:599–605. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sjögren S, Inganäs M, Lindgren A, Holmberg
L and Bergh J: Prognostic and predictive value of c-erbB-2
overexpression in primary breast cancer, alone and in combination
with other prognostic markers. J Clin Oncol. 16:462–469. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Voduc KD, Cheang MC, Tyldesley S, Gelmon
K, Nielsen TO and Kennecke H: Breast cancer subtypes and the risk
of local and regional relapse. J Clin Oncol. 28:1684–1691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui X, Schiff R, Arpino G, Osborne CK and
Lee AV: Biology of progesterone receptor loss in breast cancer and
its implications for endocrine therapy. J Clin Oncol. 23:7721–7735.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas C and Gustafsson JÅ: The different
roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer.
11:597–608. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX,
Shetuni B and Barsky SH: ERalpha signaling through slug regulates
E-cadherin and EMT. Oncogene. 29:1451–1462. 2010. View Article : Google Scholar : PubMed/NCBI
|
